Two Sigma Investments
AVXL icon

Two Sigma Investments’s Anavex Life Sciences AVXL Stock Holding History

Two Sigma Investments’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$9.97M Buy
3,247,888
+1,594,192
+96% +$6.9M 0.01% 1411
2025
Q4 		$5.89M Buy
1,653,696
+616,742
+59% +$3.78M 0.01% 1564
2025
Q3 		$9.23M Buy
1,036,954
+63,685
+7% +$646K 0.01% 1008
2025
Q2 		$8.97M Buy
973,269
+113,171
+13% +$966K 0.02% 876
2025
Q1 		$7.38M Buy
860,098
+83,197
+11% +$786K 0.02% 912
2024
Q4 		$8.34M Sell
776,901
-53,723
-6% -$413K 0.02% 844
2024
Q3 		$4.72M Sell
830,624
-182,259
-18% -$1.05M 0.01% 1121
2024
Q2 		$4.27M Buy
1,012,883
+477,336
+89% +$1.93M 0.01% 1080
2024
Q1 		$2.73M Buy
535,547
+489,046
+1,052% +$2.75M 0.01% 1282
2023
Q4 		$433K Sell
46,501
-82,515
-64% -$568K ﹤0.01% 2537
2023
Q3 		$845K Buy
129,016
+12,716
+11% +$101K ﹤0.01% 2030
2023
Q2 		$946K Sell
116,300
-143,730
-55% -$1.23M ﹤0.01% 1972
2023
Q1 		$2.23M Buy
260,030
+115,258
+80% +$1.15M 0.01% 1321
2022
Q4 		$1.34M Buy
144,772
+1,986
+1% +$21.2K ﹤0.01% 1550
2022
Q3 		$1.47M Buy
142,786
+63,216
+79% +$667K 0.01% 1290
2022
Q2 		$796K Sell
79,570
-37,263
-32% -$353K ﹤0.01% 1639
2022
Q1 		$1.44M Buy
+116,833
New +$1.44M ﹤0.01% 1504

Other funds holding AVXL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
SF
Summit Financial Parsippany, New Jersey $7.85B AUM 20.99% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Two Sigma Investments's AVXL Position: Q1 2026 in Review

Two Sigma Investments increased its Anavex Life Sciences (AVXL) stake by 96% in Q1 2026, buying an estimated $6.9M and bringing the position to 3,247,888 shares worth $9.97M. The position accounts for 0.01% of the portfolio, ranked #1411.

Two Sigma Investments first reported a position in AVXL in Q1 2022 and has held it in 17 quarters since. 190 funds tracked by Wall St. Rank hold AVXL as of Q1 2026.

  • Two Sigma Investments held 3,247,888 shares of Anavex Life Sciences worth $9.97M as of Q1 2026.
  • Two Sigma Investments bought 1,594,192 Anavex Life Sciences shares in Q1 2026, an estimated $6.9M.
  • Anavex Life Sciences made up 0.01% of Two Sigma Investments's portfolio in Q1 2026, its #1411 holding.
  • Two Sigma Investments first reported a position in Anavex Life Sciences in Q1 2022 and has held it in 17 quarters since.
  • 190 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q1 2026.

Based on Two Sigma Investments's 13F filing for Q1 2026, filed 15 May 2026.